About Medcura
Medcura is a company based in United States founded in 2019. Medcura has raised $87.35 million across 6 funding rounds from investors including TEDCO. Medcura offers products and services including LifeGel and Hemostasis Portfolio. Medcura operates in a competitive market with competitors including Hemotune, ExThera Medical, Lindis Blood Care, CytoPherx and ArtBlood, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$87.35 M (USD)
in 6 rounds
-
Latest Funding Round
$28.55 M (USD), Series C
Apr 16, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medcura
Medcura offers a comprehensive portfolio of products and services, including LifeGel and Hemostasis Portfolio.
Flowable gel for controlling bleeding in surgical procedures
Biopolymer solutions for minimal to moderate bleeding management
People of Medcura
Unlock access to complete
Unlock access to complete
Funding Insights of Medcura
Medcura has successfully raised a total of $87.35M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $28.55 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medcura
Medcura has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Locked | Locked | Locked |
Investor details for Medcura
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medcura
Investment portfolio details for Medcura
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medcura
Detailed financials for Medcura
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medcura Comparisons
Peer comparison for Medcura
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medcura
Medcura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, ExThera Medical, Lindis Blood Care, CytoPherx and ArtBlood, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| Locked | Locked | Locked |
Innovative solutions for safer blood transfusions are developed.
|
|
| Locked | Locked | Locked |
Cytopheresis systems for inflammatory conditions
|
|
| Locked | Locked | Locked |
Developer of a cell-based extracorporeal blood production system
|
Detailed competitors of Medcura
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medcura
Complete news archive for Medcura
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medcura
Medcura was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Medcura is headquartered in United States.
Medcura is a funded company, having raised a total of $87.35M across 6 funding rounds to date.
Developer of the device for controlling bleeding. The product Triple R is used to rapidly and decisively stop bleeding after diagnostic and interventional vascular access procedures, Life Foam s a self-expanding injectable biopolymer foam to treat internal non-specific hemorrhage, LifeGel for treating bleeding from parenchymal tissue, and Rapid-Seal provides an antibacterial barrier.
Medcura's top competitors include ExThera Medical, Lindis Blood Care and ArtBlood.
Medcura offers LifeGel and Hemostasis Portfolio.
Medcura has 1 investor. Key investors include TEDCO.